Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;48(4):799-815.
doi: 10.1007/s40618-024-02503-2. Epub 2025 Jan 6.

Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult

Affiliations
Review

Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult

Maria Rosaria Ambrosio et al. J Endocrinol Invest. 2025 Apr.

Abstract

Aim: This review aims to overview factors contributing to TAO development and addresses the targeted diagnostic work-up and treatment management in adult thalassemic patients.

Results: Osteoporosis management in Thalassemia is challenging because several factors contributing to its pathogenesis should be considered and controlled starting from child- hood. A multidisciplinary approach is crucial. Evidence concerning the efficacy of available anti-osteoporosis drugs in thalassemic patients is scarce. In this scenario, clinical experience and center resources often guide the treatment choice. More efforts should be made to share knowledge in this field in order to indicate specific treatment strategies for TAO management.

Methods: We performed a literature search in Pubmed from 1992 to March 2024 using the words Thalassemia and: osteoporosis, Bisphosphonates, Denosumab, Teriparatide, Romosozumab, hormone replacement therapy, growth hormone, hypogonadism, calcium, vitamin D, bone disease, sarcopenia. The search was limited to English literature including original studies, reviews, meta-analyses, case reports.

Keywords: Fracture.; Osteoporosis; Thalassemia; Thalassemia-associated osteoporosis.

PubMed Disclaimer

References

    1. Ishimoto AK, Shah AA (2024) Screening and early treatment for osteoporosis: who are we missing under age 65? Maturitas 187:108044 - PubMed
    1. Taher AT, Musallam KM, Cappellini MD (2021) β-Thalassemias. Longo DL, editor. N Engl J Med.;384(8):727–43
    1. Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR et al (2005) Survival and complications in Thalassemia. Ann N Y Acad Sci 1054:40–47 - PubMed
    1. Tuo Y, Li Y, Li Y et al (2024) Global, regional, and national burden of Thalassemia, 1990–2021: a systematic analysis for the global burden of disease study 2021. EClinicalMedicine 72:102619 - PubMed - PMC
    1. Bhardwaj A, Swe KMM, Sinha NK, Osunkwo I (2016) Treatment for osteoporosis in people with ß-thalassaemia. Cochrane Database Syst Rev 3:CD010429 - PubMed

Substances

LinkOut - more resources